Literature DB >> 15538747

Phosphoproteomics by mass spectrometry and classical protein chemistry approaches.

Erdjan Salih1.   

Abstract

The general fields of biological sciences have seen phenomenal transformations in the past two decades at the level of data acquisition, understanding biological processes, and technological developments. Those advances have been made partly because of the advent of molecular biology techniques (which led to genomics) coupled to the advances made in mass spectrometry (MS) to provide the current capabilities and developments in proteomics. However, our current knowledge that approximately 30,000 human genes may code for up to 1 million or more proteins disengage the interface between the genome sequence database algorithms and MS to generate a major interest in independent de novo MS/MS sequence determination. Significant progress has been made in this area through procedures to covalently modify peptide N- and C-terminal amino-acids by sulfonation and guanidination to permit rapid de novo sequence determination by MS/MS analysis. A number of strategies that have been developed to perform qualitative and quantitative proteomics range from 2D-gel electrophoresis, affinity tag reagents, and stable-isotope labeling. Those procedures, combined with MS/MS peptide sequence analysis at the subpicomole level, permit the rapid and effective identification and quantification of a large number of proteins within a given biological sample. The identification of proteins per se, however, is not always sufficient to interpret biological function because many of the naturally occurring proteins are post-translationally modified. One such modification is protein phosphorylation, which regulates a large array of cellular biochemical pathways of the biological system. Traditionally, the study of phosphoprotein structure-function relationships involved classical protein chemistry approaches that required protein purification, peptide mapping, and the identification of the phosphorylated peptide regions and sites by N-terminal sequence analysis. Recent advances made in mass spectrometry have clearly revolutionized the studies of phosphoprotein biochemistry, and include the development of specific strategies to preferentially enrich phosphoproteins by covalent-modifications that incorporate affinity tags that use the physicochemical properties of phosphoaminoacids. The phosphoserine/phosphothreonine-containing proteins/peptides are derivatized under base-catalyzed conditions by thiol agents; mono- and di-thiol reagents both have been used in such studies. The thiol agent may have: (i) an affinity tag for protein enrichment; (ii) stable-isotopic variants for relative quantitation; or (iii) a combination of the moieties in (i) and (ii). These strategies and techniques, together with others, are reviewed, including their practical application to the study of phosphoprotein biochemistry and structure-function. The consensus of how classical protein chemistry and current MS technology overlap into special case of proteomics, namely "phosphoproteomics," will be discussed. (c) 2004 Wiley Periodicals, Inc., Mass Spec Rev 24:828-846, 2005.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15538747     DOI: 10.1002/mas.20042

Source DB:  PubMed          Journal:  Mass Spectrom Rev        ISSN: 0277-7037            Impact factor:   10.946


  23 in total

Review 1.  Chasing phosphohistidine, an elusive sibling in the phosphoamino acid family.

Authors:  Jung-Min Kee; Tom W Muir
Journal:  ACS Chem Biol       Date:  2011-12-09       Impact factor: 5.100

2.  Metastable atom-activated dissociation mass spectrometry of phosphorylated and sulfonated peptides in negative ion mode.

Authors:  Shannon L Cook; Glen P Jackson
Journal:  J Am Soc Mass Spectrom       Date:  2011-04-12       Impact factor: 3.109

3.  Intramolecular and intermolecular uridylylation by poliovirus RNA-dependent RNA polymerase.

Authors:  Oliver C Richards; Jeannie F Spagnolo; John M Lyle; Susan E Vleck; Robert D Kuchta; Karla Kirkegaard
Journal:  J Virol       Date:  2006-08       Impact factor: 5.103

Review 4.  Protein abundance ratios for global studies of prokaryotes.

Authors:  Qiangwei Xia; Erik L Hendrickson; Tiansong Wang; Richard J Lamont; John A Leigh; Murray Hackett
Journal:  Proteomics       Date:  2007-08       Impact factor: 3.984

Review 5.  Methods and approaches for the comprehensive characterization and quantification of cellular proteomes using mass spectrometry.

Authors:  Shama P Mirza; Michael Olivier
Journal:  Physiol Genomics       Date:  2007-12-27       Impact factor: 3.107

Review 6.  Detection and analysis of protein histidine phosphorylation.

Authors:  Paul G Besant; Paul V Attwood
Journal:  Mol Cell Biochem       Date:  2009-04-23       Impact factor: 3.396

7.  Nucleophosmin Phosphorylation as a Diagnostic and Therapeutic Target for Ischemic AKI.

Authors:  Zhiyong Wang; Erdjan Salih; Chinaemere Igwebuike; Ryan Mulhern; Ramon G Bonegio; Andrea Havasi; Steven C Borkan
Journal:  J Am Soc Nephrol       Date:  2019-01       Impact factor: 10.121

8.  The influence of sample preparation and replicate analyses on HeLa Cell phosphoproteome coverage.

Authors:  Bryan M Ham; Feng Yang; Hemalatha Jayachandran; Navdeep Jaitly; Matthew E Monroe; Marina A Gritsenko; Eric A Livesay; Rui Zhao; Samuel O Purvine; Daniel Orton; Joshua N Adkins; David G Camp; Sandra Rossie; Richard D Smith
Journal:  J Proteome Res       Date:  2008-04-16       Impact factor: 4.466

9.  Large-scale Arabidopsis phosphoproteome profiling reveals novel chloroplast kinase substrates and phosphorylation networks.

Authors:  Sonja Reiland; Gaëlle Messerli; Katja Baerenfaller; Bertran Gerrits; Anne Endler; Jonas Grossmann; Wilhelm Gruissem; Sacha Baginsky
Journal:  Plant Physiol       Date:  2009-04-17       Impact factor: 8.340

10.  Detecting the site of phosphorylation in phosphopeptides without loss of phosphate group using MALDI TOF mass spectrometry.

Authors:  Medicharla V Jagannadham; Ramakrishnan Nagaraj
Journal:  Anal Chem Insights       Date:  2008-02-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.